Subject Areas on Research
- A case series of recombinant platelet factor 4 for heparin reversal after cardiopulmonary bypass.
- A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the EVOLUTION-ON study.
- A reliable, nondestructive animal model for interstitial cystitis: intravesical low-dose protamine sulfate combined with physiological concentrations of potassium chloride.
- Antibodies against heparin-protamine complexes: Effect and clinical relevance.
- Anticoagulant therapy during cardiopulmonary bypass.
- Anticoagulation and reversal paradigms: is too much of a good thing bad?
- Anticoagulation with bivalirudin for off-pump coronary artery bypass grafting: the results of the EVOLUTION-OFF study.
- Do anticoagulation with heparin and protamine reversal alter thrombogenicity of coated and noncoated pulmonary artery catheters?
- Efficacy and safety of heparinase I versus protamine in patients undergoing coronary artery bypass grafting with and without cardiopulmonary bypass.
- Hemostatic agents and their safety.
- Heparin anticoagulation in patients undergoing off-pump and on-pump coronary bypass surgery.
- Heparin neutralization by recombinant platelet factor 4 and protamine.
- Heparin neutralization with methylene blue, hexadimethrine, or vancomycin after cardiopulmonary bypass.
- Heparinase I (neutralase) reversal of systemic anticoagulation.
- High incidence of antibodies to protamine and protamine/heparin complexes in patients undergoing cardiopulmonary bypass.
- Novel pharmacologic approaches to reduce bleeding.
- Predicting and treating coagulopathies after cardiopulmonary bypass in children.
- Protamine and its cardiovascular effects.
- Protamine reversal of heparin affects platelet aggregation and activated clotting time after cardiopulmonary bypass.
- Protamine-induced immune thrombocytopenia.
- Rapid evaluation of coagulopathies after cardiopulmonary bypass in children using modified thromboelastography.
- The anticoagulant effect of protamine sulfate is attenuated in the presence of platelets or elevated factor VIII concentrations.
Keywords of People
- Arepally, Gowthami Morey, Professor of Medicine, Pathology